Bal Pharma gained 12.29% or Rs 3.70 to end at Rs 33.80. It touched an intraday high of Rs 35 and an intraday low of Rs 28.40. There were pending buy orders of 2,041 shares, with no sellers available. The total traded volumes were of 99,872 shares.
Bal Pharma specializes in Prescription drugs, Generics, OTC products, Intravenous Infusion and Bulk Actives with almost 19 years of experience behind it. The company touched its 52 week high Rs 46.60 and 52 week low Rs 25.60 on 02 Nov, 2010 and 26 Feb, 2010, respectively. Currently, it is trading -27.47% below its 52-week high and 32.03% above its 52-week low. Its market capitalisation stands at Rs 35.43 crore. The company's trailing 12-month (TTM) EPS was at Rs -1.11 per share. (Sep, 2010). The latest book value of the company is Rs 34.37 per share. At current value, the price-to-book value of the company was 0.98. Peers Comparison:| Company | Last Price (Rs) | Market Cap (Rs in Cr) | Sales Turnover (Rs in Cr) | PAT (Rs in Cr) |
| Sun Pharma | 493.35 | 51090.44 | 3861.55 | 1265.29 |
| Cipla | 357 | 28664.29 | 5624.91 | 1081.49 |
| Dr Reddys Labs | 1672.65 | 28305.81 | 4553.21 | 846.08 |
| Ranbaxy Labs | 589.4 | 24816.14 | 4782.76 | 571.98 |
| Lupin | 473.7 | 21122.38 | 3708.51 | 648.93 |
| GlaxoSmithKline | 2376.75 | 20131.79 | 1892.96 | 512.29 |
| Cadila Health | 771.2 | 15790.21 | 1945.72 | 265.91 |
| Piramal Health | 474.65 | 9920.81 | 2666.21 | 443.22 |
| Glenmark | 359.75 | 9710.95 | 856.11 | 217.93 |
| Divis Labs | 636 | 8431.16 | 1203.49 | 421.26 |
| Bal Pharma | 33.8 | 35.43 | 108.14 | -1.24 |
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
